Register | Forgot Your Password? | Close

BOSTON (AP) - A Massachusetts drug company with the same founders as a compounding pharmacy tied to a deadly meningitis outbreak has agreed with state regulators to remain closed through the year.

Ameridose first agreed to close for inspection in October after tainted steroids from its sister company, the New England Compounding Center, were linked to a fungal meningitis outbreak that caused 32 deaths. The agreement has been extended several times. The latest would have expired Monday.

Ameridose has laid off most workers and recalled its products, though none has been found contaminated. The company makes injectable drugs for hospitals.

The U.S. Food and Drug Administration said Monday that its monthlong inspection of Ameridose found potential sources of contamination, including leaky ceilings and insects. Ameridose has said it'll work to address those issues.


(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
share this story:
Attention KTAR.com Comment Users: We have recently changed our comments boards.
We would like you to be part of the conversation and The Voice of Arizona by logging in with your Facebook, Twitter, Google+ or Disqus account. Existing KTAR (Arizona Sports) account members will need to create a Disqus account or use one of the aforementioned social media logins. Thank you.
comments powered by Disqus